Development of an innovative multichannel device for training EEG neurofeedback with virtual reality for effective evidence-based treatment based on scientific evidence. (Q77758): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Fixing rounding issue)
(‎Removed claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The aim of the project is to develop an innovative multichannel device for training EEG neurofeedback (‘EEG-NFB’) using a virtual reality allowing effective...)
Property / summary
Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The aim of the project is to develop an innovative multichannel device for training EEG neurofeedback (‘EEG-NFB’) using a virtual reality allowing effective clinical treatment, based on evidence based on scientific evidence (Evidence Based Practice).The currently used EEG neurofeedback does not provide an adequate level of training performance.The apparatus will be used for the treatment of:(1) The psychomotor disorder (ADHD) (2).The equipment will be placed on the market:Poland = 0,194 millionEurope 28 + 1 = 2,6 million US = 2,32 millionTotal target population:5,1 millionThe actual level of the target market will increase by 30 % comparing the year to the year.The apparatus will be manufactured and distributed on its own network and commercial structures developed since 1978.The research project is currently in Phase II of Technological Readiness Level and will consist of 4 phases of ETAP 1:The creation of a basic model and a tool to start research on a multichannel bioyield visualisation with a stereoscopic visualisation, ETAP 2:The formation of a tested model, pre-calibrated and parameterised.STAGE 3:the development of a model with full clinical benefit.STAGE 4:preparation for implementation, development of a prototype.Research activities will be carried out in the framework of its own R & D team. the effectiveness of the new device will be confirmed by a study on the use of EEG techniques using EEG technology and fMRI by the Institute of Biology, M. Nenocki PAN, based on around 3600 test exercises. (English)
 
Property / summary: Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The aim of the project is to develop an innovative multichannel device for training EEG neurofeedback (‘EEG-NFB’) using a virtual reality allowing effective clinical treatment, based on evidence based on scientific evidence (Evidence Based Practice).The currently used EEG neurofeedback does not provide an adequate level of training performance.The apparatus will be used for the treatment of:(1) The psychomotor disorder (ADHD) (2).The equipment will be placed on the market:Poland = 0,194 millionEurope 28 + 1 = 2,6 million US = 2,32 millionTotal target population:5,1 millionThe actual level of the target market will increase by 30 % comparing the year to the year.The apparatus will be manufactured and distributed on its own network and commercial structures developed since 1978.The research project is currently in Phase II of Technological Readiness Level and will consist of 4 phases of ETAP 1:The creation of a basic model and a tool to start research on a multichannel bioyield visualisation with a stereoscopic visualisation, ETAP 2:The formation of a tested model, pre-calibrated and parameterised.STAGE 3:the development of a model with full clinical benefit.STAGE 4:preparation for implementation, development of a prototype.Research activities will be carried out in the framework of its own R & D team. the effectiveness of the new device will be confirmed by a study on the use of EEG techniques using EEG technology and fMRI by the Institute of Biology, M. Nenocki PAN, based on around 3600 test exercises. (English) / rank
Normal rank
 

Revision as of 10:16, 14 October 2020

Project in Poland financed by DG Regio
Language Label Description Also known as
English
Development of an innovative multichannel device for training EEG neurofeedback with virtual reality for effective evidence-based treatment based on scientific evidence.
Project in Poland financed by DG Regio

    Statements

    contained in NUTS
    Miasto Warszawa
    0 references
    Gliwicki
    0 references
    country
    Poland
    0 references
    EU contribution
    9,450,641.95 zloty
    0 references
    2,268,154.07 Euro
    exchange rate to Euro
    0.24 Euro
    point in time
    13 January 2020
    0 references
    budget
    12,106,934.0 zloty
    0 references
    2,905,664.16 Euro
    exchange rate to Euro
    0.24 Euro
    point in time
    13 January 2020
    0 references
    co-financing rate
    78.06 percent
    0 references
    start time
    1 October 2015
    0 references
    end time
    31 May 2020
    0 references
    beneficiary name (string)
    ELMIKO BIOSIGNALS SP. Z O.O.
    0 references
    beneficiary
    Q2509620
    0 references
    coordinate location

    52°14'1.3"N, 21°4'17.0"E
    0 references

    50°18'4.0"N, 18°39'44.3"E
    0 references
    summary
    Numer_referencyjny_programu_pomocowego: SA.41471(2015/X) Przeznaczenie_pomocy_publicznej: art. 25 rozporządzenia KE nr 651/2014 z dnia 17 czerwca 2014 r. uznające niektóre rodzaje pomocy za zgodne z rynkiem wewnętrznym w stosowaniu art. 107 i 108 Traktatu (Dz. Urz. UE L 187/1 z 26.06.2014). Celem projektu jest opracowanie innowacyjnego wielokanałowego urządzenia do treningu EEG-neurofeedback („EEG-NFB”) z zastosowaniem wirtualnej rzeczywistości umożliwiającego skuteczną terapię kliniczną, w oparciu o dowody naukowe (Evidence Based Practice). Obecnie stosowane aparaty EEG-neurofeedback nie zapewniają odpowiedniego poziomu skuteczności treningu. Urządzenie znajdzie zastosowanie w terapiach: (1) Zespołu nadpobudliwości psychoruchowej (ADHD) (2) Zaburzeń Obsesyjno-Kompulsywnych (3) Epilepsji. Urządzenie trafi do rynków docelowego: Polska = 0,194 mln os. Europa 28 +1 = 2,6 mln os USA = 2,32 mln os. Razem populacja rynku docelowego: 5,1 mln os. Rzeczywisty poziom rynku docelowego będzie rosnąć w tempie 30 % porównując rok do roku. Urządzenie będzie produkowane i dystrybuowane we własnej sieci i struktur handlowych powstałych rozwijanych od 1978 roku. w ramach Polskiej rodzinnej grupy firm Elmiko. Projekt badawczy jest aktualnie na II poziomie gotowości technologicznej i będzie składał się z 4 etapów ETAP 1: Powstanie podstawowego modelu i narzędzia umożliwiającego rozpoczęcie badań nad wielokanałowym biofeedbackiem ze stereoskopową wizualizacją, ETAP 2: Powstanie przetestowanego modelu, wstępnie skalibrowanego i sparametryzowanego. ETAP 3: powstanie modelu o pełnej użyteczności klinicznej. ETAP 4: przygotowanie do wdrożenia, stworzenie prototypu. Prace badawcze będą odbywać się w ramach własnego zespołu B+R. Skuteczność nowego urządzenia zostanie potwierdzona badaniami obrazowania mózgu prowadzonymi z uzyciem technik EEG i fMRI przez Instytut Biologii Doświadczalnej im. M. Nenckiego PAN , na bazie około 3600 treningów testowych . (Polish)
    0 references

    Identifiers

    Polish Kohesio ID
    POIR.01.01.01-00-0178/15
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q77758&oldid=6325204"